Trends in observation stays for Medicare beneficiaries with and without Alzheimer's disease and related dementias

被引:0
|
作者
Burke, Laura G. [1 ,2 ,3 ,7 ,8 ]
Burke, Ryan C. [1 ,3 ]
Duggan, Ciara E. [3 ]
Figueroa, Jose F. [3 ]
Boltz, Marie [4 ]
Fick, Donna M. [4 ]
Orav, E. John [5 ]
Marcantonio, Edward R. [2 ,6 ]
机构
[1] Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA USA
[2] Harvard Med Sch, Boston, MA USA
[3] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA
[4] Penn State Univ, Coll Nursing, University Pk, PA USA
[5] Brigham & Womens Hosp, Div Gen Internal Med, Boston, MA USA
[6] Beth Israel Deaconess Med Ctr, Dept Med, Div Gen Med & Gerontol, Boston, MA USA
[7] Beth Israel Deaconess Med Ctr, Dept Emergency Med, 1 Deaconess Rd, Boston, MA 02215 USA
[8] Harvard Med Sch, 1 Deaconess Rd, Boston, MA 02215 USA
关键词
Alzheimer's disease; dementia; emergency medicine; Medicare; observation; EMERGENCY-DEPARTMENT; CARE; DISPARITIES; REDUCTION; MORTALITY; COSTS;
D O I
10.1111/jgs.18890
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
BackgroundThere has been a marked rise in the use of observation care for Medicare beneficiaries visiting the emergency department (ED) in recent years. Whether trends in observation use differ for people with Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD) is unknown. MethodsUsing a national 20% sample of Medicare beneficiaries ages 68+ from 2012 to 2018, we compared trends in ED visits and observation stays by AD/ADRD status for beneficiaries visiting the ED. We then examined the degree to which trends differed by nursing home (NH) residency status, assigning beneficiaries to four groups: AD/ADRD residing in NH (AD/ADRD+ NH+), AD/ADRD not residing in NH (AD/ADRD+ NH-), no AD/ADRD residing in NH (AD/ADRD- NH+), and no AD/ADRD not residing in NH (AD/ADRD- NH-). ResultsOf 7,489,780 unique beneficiaries, 18.6% had an AD/ADRD diagnosis. Beneficiaries with AD/ADRD had more than double the number of ED visits per 1000 in all years compared to those without AD/ADRD and saw a faster adjusted increase over time (+26.7 vs. +8.2 visits/year; p < 0.001 for interaction). The annual increase in the adjusted proportion of ED visits ending in observation was also greater among people with AD/ADRD (+0.78%/year, 95% CI 0.77-0.80%) compared to those without AD/ADRD (+0.63%/year, 95% CI 0.59-0.66%; p < 0.001 for interaction). Observation utilization was greatest for the AD/ADRD+ NH+ population and lowest for the AD/ADRD- NH- population, but the AD/ADRD+ NH- group saw the greatest increase in observation stays over time (+15.4 stays per 1000 people per year, 95% CI 15.0-15.7). ConclusionsMedicare beneficiaries with AD/ADRD have seen a disproportionate increase in observation utilization in recent years, driven by both an increase in ED visits and an increase in the proportion of ED visits ending in observation.
引用
收藏
页码:1442 / 1452
页数:11
相关论文
共 50 条
  • [41] Medicare Advantage Enrollment and Disenrollment Among Persons With Alzheimer Disease and Related Dementias
    James, Hannah O.
    Trivedi, Amal N.
    Meyers, David J.
    [J]. JAMA HEALTH FORUM, 2023, 4 (09): : E233080
  • [42] POLYPHARMACY AND THE SYMPTOM EXPERIENCE OF OLDER ADULTS WITH AND WITHOUT ALZHEIMER'S DISEASE AND RELATED DEMENTIAS
    Coates, Martha
    McClure, Leslie
    Finley, Margaret
    Sefcik, Justine
    Gitlin, Laura
    DiMaria-Ghalili, Rose Ann
    [J]. INNOVATION IN AGING, 2023, 7 : 414 - 414
  • [43] How a Medicare payment model is affecting care for older adults with Alzheimer's disease and related dementias
    Hung, Anna
    Hall, Rasheeda
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2022, 70 (09) : 2478 - 2480
  • [44] Early identification of Alzheimer's disease and related dementias
    Costa, PT
    Williams, TF
    Albert, MS
    Butters, NM
    Folstein, MF
    Gilman, S
    Gurland, BJ
    Gwyther, LP
    Heyman, A
    Kaszniak, AW
    Katz, IR
    Lanska, D
    Levy, LL
    Lombardo, NE
    OrrRainey, NK
    Phillips, LR
    Storandt, M
    Tangalos, EG
    Wykle, ML
    Bayles, K
    Bulatao, EQ
    Francis, R
    Hollis, C
    Kirk, JW
    Rice, D
    Stephenson, G
    Trainer, TV
    VandenBos, GV
    Weisman, C
    [J]. AMERICAN FAMILY PHYSICIAN, 1997, 55 (04) : 1303 - 1314
  • [45] Combination therapy for Alzheimer's disease and related dementias
    Bednar, Martin M.
    [J]. MOLECULAR BIOLOGY OF NEURODEGENERATIVE DISEASES: VISIONS FOR THE FUTURE, PT A, 2019, 168 : 289 - 296
  • [46] Neuropsychiatry of Alzheimer's disease and related dementias.
    Kirrane, R
    [J]. IRISH JOURNAL OF PSYCHOLOGICAL MEDICINE, 2003, 20 (04) : 138 - 139
  • [47] Neuropsychiatric assessment of Alzheimer's disease and related dementias
    Cummings, JL
    McPherson, S
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2001, 13 (03) : 240 - 246
  • [48] ALZHEIMER'S DISEASE AND RELATED DEMENTIAS IN A FAMILY CONTEXT
    Suitor, J. Jill
    Gilligan, Megan
    [J]. INNOVATION IN AGING, 2023, 7 : 17 - 17
  • [49] Alzheimer's disease and related dementias: the road to intervention
    Tanzi, RE
    [J]. EXPERIMENTAL GERONTOLOGY, 2000, 35 (04) : 433 - 437
  • [50] A grand plan for Alzheimer's disease and related dementias
    不详
    [J]. LANCET NEUROLOGY, 2012, 11 (03): : 201 - 201